1. Home
  2. JXJT vs NLSP Comparison

JXJT vs NLSP Comparison

Compare JXJT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXJT
  • NLSP
  • Stock Information
  • Founded
  • JXJT 2012
  • NLSP 2015
  • Country
  • JXJT China
  • NLSP Switzerland
  • Employees
  • JXJT N/A
  • NLSP N/A
  • Industry
  • JXJT Apparel
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JXJT Consumer Staples
  • NLSP Health Care
  • Exchange
  • JXJT Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • JXJT 8.1M
  • NLSP 8.2M
  • IPO Year
  • JXJT 2012
  • NLSP 2021
  • Fundamental
  • Price
  • JXJT $1.46
  • NLSP $0.19
  • Analyst Decision
  • JXJT
  • NLSP Hold
  • Analyst Count
  • JXJT 0
  • NLSP 1
  • Target Price
  • JXJT N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • JXJT 665.7K
  • NLSP 10.5M
  • Earning Date
  • JXJT 08-14-2024
  • NLSP 08-06-2024
  • Dividend Yield
  • JXJT N/A
  • NLSP N/A
  • EPS Growth
  • JXJT N/A
  • NLSP N/A
  • EPS
  • JXJT 0.48
  • NLSP N/A
  • Revenue
  • JXJT $31,840,588.00
  • NLSP N/A
  • Revenue This Year
  • JXJT N/A
  • NLSP N/A
  • Revenue Next Year
  • JXJT N/A
  • NLSP N/A
  • P/E Ratio
  • JXJT $2.81
  • NLSP N/A
  • Revenue Growth
  • JXJT N/A
  • NLSP N/A
  • 52 Week Low
  • JXJT $1.04
  • NLSP $0.11
  • 52 Week High
  • JXJT $8.51
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • JXJT 61.86
  • NLSP 50.74
  • Support Level
  • JXJT $1.13
  • NLSP $0.17
  • Resistance Level
  • JXJT $1.33
  • NLSP $0.24
  • Average True Range (ATR)
  • JXJT 0.17
  • NLSP 0.02
  • MACD
  • JXJT 0.01
  • NLSP -0.00
  • Stochastic Oscillator
  • JXJT 58.04
  • NLSP 29.41

About JXJT JX Luxventure Limited

JX Luxventure Ltd is engaged in the business of menswear, cross-border merchandise, airfare, and tourism. The company operates in three segments Tourism products, Technology and Cross- board merchandise. The majority of the group revenue is generated from the Tourism products.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: